Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Bioentrepreneur
  • Published:

Do you really want to be a biotech board member?

Nature Biotechnology volume 31, pages 1072–1074 (2013)Cite this article

There are many advantages to becoming a company advisor, but academics should think carefully about the legal and personal implications before accepting a seat on the board.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Mark Kessel is of counsel at Shearman & Sterling LLP, New York, New York, USA.,

    Mark Kessel

Authors
  1. Mark Kessel
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Mark Kessel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kessel, M. Do you really want to be a biotech board member?. Nat Biotechnol 31, 1072–1074 (2013). https://doi.org/10.1038/nbt.2763

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt.2763

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing